Economic analysis of implementing virtual reality therapy for pain among hospitalized patients

Tornado Analysis. Results of the multiple univariate sensitivity analysis testing the influence of variables on the model. Each bar demonstrates the range of cost-savings potential associated with the range (described in parentheses) tested for various variables (described in text next to each bar). A black indentation on the left-side of a bar indicates that the lowest value of cost-savings associated with the variable over the range tested is zero. The cost savings potential of the VR therapy program was most dependent on patient acceptance and eligibility and percent reduction in patient length of stay. Other significant factors include ORADE rate, costs of VR, number of admissions per year, and the degree to which VR therapy decreases opioid utilization. The probability of patients selecting the best possible answers on the HCAHPS survey had the least impact on the outcome of the model, and was not included in this figure. VR, virtual reality; ORADE, opioid-related adverse drug event; HCAHPS, Hospital Consumer Assessment of Healthcare Providers and System